(Q48622745)

13 February 2018

title

Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. (English)

1 reference

13 February 2018

0 references

Karlein M G Schreurs

1

1 reference

13 February 2018

Denise T D de Ridder

series ordinal

2

1 reference

13 February 2018

Jozien M Bensing

series ordinal

3

1 reference

13 February 2018

publication date

1 September 2002

1 reference

13 February 2018

Journal of Psychosomatic Research

published in

1 reference

13 February 2018

volume

53

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

775-781

1 reference

13 February 2018

Fatigue in Multiple Sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Psychosocial correlates of fatigue in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

The nature of fatigue in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Quality of life among persons with multiple sclerosis and their caregivers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Fatigue in Multiple Sclerosis: Guidelines for Nursing Care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

The epidemiology of fatigue and depression: a French primary-care study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Adaptive tasks, coping and quality of life of chronically ill patients: the cases of Parkinson's disease and chronic fatigue syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Identification of Beck Depression Inventory items related to multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Fatigue and radiotherapy: (B) experience in patients 9 months following treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Fatigue and radiotherapy: (A) experience in patients undergoing treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

The measurement of fatigue: A new instrument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Development of a fatigue scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Amantadine therapy for fatigue in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Amantadine, fatigue, and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Amantadine treatment of fatigue associated with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

Fatigue in MS is associated with specific clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Symptomatic therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Negative affect and self-report of physical symptoms: two longitudinal studies of older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900326-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3999(02)00326-4

1 reference

13 February 2018

1 reference

13 February 2018